In addition, Liu and colleagues established a method named PLA‐RPA‐TMA assay: two proximity ligation assay (PLA) probes recognize biomarkers such as LMP or EGFR protein on tumor‐derived EVs in NPC, and then generate the unique surrogate DNA signal for these biomarkers. Here, EGFR is linked to neoplasm.